These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 22032309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM.
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [Abstract] [Full Text] [Related]

  • 3. [Pulmonary arterial hypertension and systemic sclerosis].
    Launay D, Humbert M, Hachulla E.
    Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
    [Abstract] [Full Text] [Related]

  • 4. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
    Ghosh SK, Corkill MM, Hart HH, Ng KP.
    N Z Med J; 2014 Aug 15; 127(1400):30-8. PubMed ID: 25145365
    [Abstract] [Full Text] [Related]

  • 5. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC, Girgis RE, Fisher MR, Champion HC, Housten-Harris T, Zaiman A, Hassoun PM.
    Eur Respir J; 2007 Mar 15; 29(3):469-75. PubMed ID: 17079256
    [Abstract] [Full Text] [Related]

  • 6. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE.
    Arthritis Rheum; 2009 Feb 15; 60(2):569-77. PubMed ID: 19180517
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
    Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M.
    Rheumatology (Oxford); 2010 Mar 15; 49(3):490-500. PubMed ID: 20015974
    [Abstract] [Full Text] [Related]

  • 8. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M, Romeo E, Argiento P, Sarubbi B, Santoro G, Grimaldi N, Correra A, Scognamiglio G, Russo MG, Calabrò R.
    Int J Cardiol; 2012 Mar 22; 155(3):378-82. PubMed ID: 21081251
    [Abstract] [Full Text] [Related]

  • 9. [Sildenafil therapy for pulmonary hypertension: a prospective study].
    Lu XL, Xiong CM, Shan GL, Liu ZH, Ni XH, Cheng XS, Gu Q, Zhao ZH, Zeng WJ, Zhu F, He JG.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun 22; 34(6):419-23. PubMed ID: 21781512
    [Abstract] [Full Text] [Related]

  • 10. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
    Lunze K, Gilbert N, Mebus S, Miera O, Fehske W, Uhlemann F, Mühler EG, Ewert P, Lange PE, Berger F, Schulze-Neick I.
    Eur J Clin Invest; 2006 Sep 22; 36 Suppl 3():32-8. PubMed ID: 16919008
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension.
    He B, Zhang F, Li X, Tang C, Lin G, Du J, Jin H.
    Circ J; 2010 Jul 22; 74(7):1458-64. PubMed ID: 20519876
    [Abstract] [Full Text] [Related]

  • 12. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP, Sheth A, Wilde M, Ong YE.
    Vascul Pharmacol; 2007 Jul 22; 47(2-3):184-8. PubMed ID: 17627899
    [Abstract] [Full Text] [Related]

  • 13. Survival after the initiation of combination therapy in patients with pulmonary arterial hypertension: an Australian collaborative report.
    Keogh A, Strange G, Kotlyar E, Williams T, Kilpatrick D, Macdonald P, Brown K, Pidoux A, Kermeen F, Steele P, Dalton B, Gabbay E.
    Intern Med J; 2011 Mar 22; 41(3):235-44. PubMed ID: 21118410
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The management of adult female patients with Eisenmenger syndrome and advanced pulmonary arterial hypertension treatment: single center experience and follow-up for 5 years].
    Taçoy G, Başer HD, Türkoğlu S, Cengel A.
    Turk Kardiyol Dern Ars; 2014 Sep 22; 42(6):531-41. PubMed ID: 25362943
    [Abstract] [Full Text] [Related]

  • 16. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL, Michelakis ED.
    Curr Opin Cardiol; 2006 Jul 22; 21(4):385-92. PubMed ID: 16755209
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
    Lim ZS, Salmon AP, Vettukattil JJ, Veldtman GR.
    Int J Cardiol; 2007 May 31; 118(2):178-82. PubMed ID: 17027100
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.